Barely Significant
← all excerpts

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

PLoS Med · 2024 · PMC11392261 · PMID 39264960

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

borderline significantp=0.05actually significant
The main result for the primary outcome is borderline significant (RR=0.85 [0.72-1.00], p=0.05), it is difficult to interpret this result.

also in 3,262 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.